newsfilter
← Latest News
GlobeNewswire·

SAB BIO Appoints Lucy To as Chief Financial Officer

MIAMI, July 31, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), ("SAB" or the "Company"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human